Release Date: 10/12/09 19:24 Summary: Response to ASX Query re Appendix 3Z Price Sensitive: No Download Document 63.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%